Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Pharmaceutics ; 15(2)2023 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-36839961

RESUMEN

Cancer continues to cause an alarming number of deaths globally, and its burden on the health system is significant. Though different conventional therapeutic procedures are exploited for cancer treatment, the prevalence and death rates remain elevated. These, therefore, insinuate that novel and more efficient treatment procedures are needed for cancer. Curcumin, a bioactive, natural, phenolic compound isolated from the rhizome of the herbaceous plant turmeric, is receiving great interest for its exciting and broad pharmacological properties. Curcumin presents anticancer therapeutic capacities and can be utilized as a photosensitizing drug in cancer photodynamic therapy (PDT). Nonetheless, curcumin's poor bioavailability and related pharmacokinetics limit its clinical utility in cancer treatment. This review looks at the physical and chemical properties, bioavailability, and safety of curcumin, while focusing on curcumin as an agent in cancer therapy and as a photosensitizer in cancer PDT. The possible mechanisms and cellular targets of curcumin in cancer therapy and PDT are highlighted. Furthermore, recent improvements in curcumin's bioavailability in cancer therapy using nanoformulations and delivery systems are presented.

2.
Front Pharmacol ; 13: 928135, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35910365

RESUMEN

The global incidence and mortality rates resulting from lung cancer encapsulate a need to identify more effective treatment protocols. Photodynamic therapy (PDT) and homeopathy offer possible anticancer therapies as part of a multi-disciplinary approach. Studies have identified the anticancer effects of Thuja occidentalis L. plant extracts. The aim of this study was to investigate the effects of Thuja occidentalis (TO) homeopathic mother tincture and TO mediated PDT (TO-PDT) on A549 lung cancer cells. Commercially available A549 cells were pre-treated with TO, or laser irradiation at 660 nm, or the combined treatment (TO-PDT). Cells were analyzed morphologically by inverted light microscopy and Hoechst stain; and biochemically by lactate dehydrogenase (LDH), adenosine triphosphate (ATP), and trypan blue assays. Cells treated with TO and TO-PDT demonstrated morphological changes in the cell and cell nuclei indicative of cell death. These groups exhibited a dose dependent increase in LDH release and a decrease in ATP levels and cell viability indicating its cytotoxic and antiproliferative potential. Furthermore, at the same doses, TO when photoactivated in PDT induced enhanced anticancer responses thereby surpassing the effects of treatment with the tincture alone. Results demonstrate how the direct cytotoxic effects of TO can be improved when administered as a photosensitizer in PDT to promote cancer cell death.

3.
Homeopathy ; 111(3): 217-225, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-34788870

RESUMEN

The continuous rise in cancer incidence places a massive burden on the health sector to increase efforts in the fight against cancer. As a holistic complementary medicine modality, homeopathy has the potential to assist in the supportive and palliative treatment of cancer patients. Recent empirical studies demonstrate the presence of silica and original source nanoparticles in ultra-high dilutions of several homeopathic medicines. Recent studies have also demonstrated the efficacy of phototherapy in inducing the ablation of cancer cells through laser-activated nanoparticle photosensitizers. A new hypothetical research model is presented herein, in an attempt to investigate and compare the phototherapeutic effects of homeopathic source nanoparticles with photosensitizing nanoparticle agents that have previously been tested.


Asunto(s)
Homeopatía , Materia Medica , Nanopartículas , Neoplasias , Humanos , Materia Medica/uso terapéutico , Nanopartículas/uso terapéutico , Neoplasias/tratamiento farmacológico , Fototerapia
4.
Antioxidants (Basel) ; 10(9)2021 Sep 14.
Artículo en Inglés | MEDLINE | ID: mdl-34573087

RESUMEN

Cancer is a condition where the body cells multiply in an uncontrollable manner. Chemoprevention of cancer is a broad term that describes the involvement of external agents to slow down or suppress cancer growth. Synthetic and natural compounds are found useful in cancer chemoprevention. The occurrence of global cancer type varies, depending on many factors such as environmental, lifestyle, genetic etc. Cancer is often preventable in developed countries with advanced treatment modalities, whereas it is a painful death sentence in developing and low-income countries due to the lack of modern therapies and awareness. One best practice to identify cancer control measures is to study the origin and risk factors associated with common types. Based on these factors and the health status of patients, stage, and severity of cancer, type of treatment is decided. Even though there are well-established therapies, cancer still stands as one of the major causes of death and a public health burden globally. Research shows that most cancers can be prevented, treated, or the incidence can be delayed. Phytochemicals from various medicinal plants were reported to reduce various risk factors associated with different types of cancer through their chemopreventive role. This review highlights the role of bioactive compounds or natural products from plants in the chemoprevention of cancer. There are many plant based dietary factors involved in the chemoprevention process. The review discusses the process of carcinogenesis and chemoprevention using plants and phytocompounds, with special reference to five major chemopreventive phytocompounds. The article also summarizes the important chemopreventive mechanisms and signaling molecules involved in the process. Since the role of antioxidants in chemoprevention is inevitable, an insight into plant-based antioxidant compounds that fight against this dreadful disease at various stages of carcinogenesis and disease progression is discussed. This will fill the research gap in search of chemopreventive natural compounds and encourage scientists in clinical trials of anticancer agents from plants.

5.
Anticancer Agents Med Chem ; 21(2): 207-213, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-32275491

RESUMEN

BACKGROUND: Cancer refers to a collection of diseases where cells begin to multiply uncontrollably. Breast cancer is the most predominant malignancy in women. Herbal medicine is one of the important health care systems in most developing countries. Many studies have shown that naturally occurring compounds may support the prevention and treatment of various diseases, including cancer. Some of the plant extracts and isolated compounds show photosensitizing activities and reduce cell proliferation whereas some have revealed photoprotective effects. OBJECTIVES: The biological properties and medicinal uses of extracts and bioactive compounds from V. nilgiriensis have not been investigated. This study aims to evaluate the cytotoxic effects of V. nilgiriensis in combination with 680nm laser irradiation on MCF-7 breast cancer cells. METHODS: The inverted microscopy, ATP and LDH assay were used to analyze the cellular morphology, proliferation, cytotoxicity respectively after the treatment with V. nilgiriensis bark extract. The diode laser of wavelength 680nm and 15 J/cm2 fluency has been used for laser irradiation. The activity of apoptotic proteins was studied using ELISA and nuclear damage by Hoechst staining. RESULTS: The exposure of V. nilgiriensis extracts with laser irradiation at 680nm increases the cytotoxicity and decreases the proliferation of MCF-7 cells. The results of the Hoechst stain indicated nuclear damage. Our study proved that V. nilgiriensis holds a strong cytotoxic effect on breast cancer cells alone and in combination with laser irradiation by upregulating the expression of apoptotic proteins such as caspase 3, p53 and Bax. CONCLUSION: The results from this study showed that the bark ethyl acetate of V. nilgiriensis and in combination with laser is effective in preventing breast cancer cell proliferation in vitro. Further work is warranted to isolate the bioactive compounds from V. nilgiriensis bark extract and study the effect of compounds in the cell death induction. Due to the cytotoxic properties, V. nilgiriensis can be considered as a potent therapeutic agent for the treatment of cancer.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Neoplasias de la Mama/terapia , Terapia por Láser , Vaccinium , Antineoplásicos Fitogénicos/química , Neoplasias de la Mama/patología , Muerte Celular/efectos de los fármacos , Muerte Celular/efectos de la radiación , Proliferación Celular/efectos de los fármacos , Proliferación Celular/efectos de la radiación , Femenino , Humanos , Células MCF-7 , Corteza de la Planta/química , Extractos Vegetales/química , Extractos Vegetales/farmacología , Vaccinium/química
6.
Oxid Med Cell Longev ; 2020: 8648742, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33014278

RESUMEN

Free radicals and oxidative stress are among the most studied factors leading to the imbalance in mental health. With no exception, free radicals also damage neuronal cells, leading to various degenerative diseases. With existing modern medications, around 80% of the world population relies on herbal medicine for various ailments. Phytochemicals in plants have a wide range of pharmacological properties, the major being their ability to scavenge free radicals. Plant polyphenols are among the major class of antioxidants identified in plants. This antioxidative property of plant compounds and their ability to downgrade the process of oxidative stress can be used to treat neurodegenerative diseases. However, selecting plants and their active compounds is a crucial step in framing the mechanism of action underlying their therapeutic potential.


Asunto(s)
Antioxidantes/uso terapéutico , Enfermedades Neurodegenerativas/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Plantas Medicinales/química , Antioxidantes/farmacología , Humanos , NADPH Oxidasas/metabolismo , FN-kappa B/metabolismo , Enfermedades Neurodegenerativas/patología , Extractos Vegetales/química , Extractos Vegetales/uso terapéutico , Plantas Medicinales/metabolismo , Polifenoles/aislamiento & purificación , Polifenoles/farmacología , Polifenoles/uso terapéutico , Especies Reactivas de Oxígeno/química , Especies Reactivas de Oxígeno/metabolismo
7.
Molecules ; 25(12)2020 Jun 24.
Artículo en Inglés | MEDLINE | ID: mdl-32599705

RESUMEN

Cancer, pain and inflammation have long been a cause for concern amongst patients, clinicians and research scientists. There is an alarming increase in the demand for medicines suppressing these disease conditions. The present study investigates the role of Syzygium mundagam bark methanol (SMBM) extract against MCF-7 breast cancer cells, pain and inflammation. The MCF-7 cells treated with SMBM were analyzed for adenosine triphosphate (ATP), lactate dehydrogenase (LDH) levels, changes in cell morphology and nuclear damage. Hot plate, acetic acid and formalin-induced pain models were followed to determine the analgesic activity. Anti-inflammatory activity was studied using carrageenan, egg albumin and cotton pellet induced rat models. Microscopic images of cells in SMBM treated groups showed prominent cell shrinkage and nuclear damage. Hoechst stain results supported the cell death morphology. The decline in ATP (47.96%) and increased LDH (40.96%) content indicated SMBM induced toxicity in MCF-7 cells. In the in vivo study, a higher dose (200 mg/kg) of the extract was found to be effective in reducing pain and inflammation. The results are promising and the action of the extract on MCF-7 cells, pain and inflammation models indicate the potential of drugs of natural origin to improve current therapies.


Asunto(s)
Analgésicos/farmacología , Antiinflamatorios no Esteroideos/farmacología , Antineoplásicos Fitogénicos/farmacología , Extractos Vegetales/farmacología , Syzygium/química , Adenosina Trifosfato/metabolismo , Analgésicos/química , Animales , Antiinflamatorios no Esteroideos/química , Antineoplásicos Fitogénicos/química , Proliferación Celular/efectos de los fármacos , Edema/inducido químicamente , Edema/tratamiento farmacológico , Femenino , Humanos , L-Lactato Deshidrogenasa/metabolismo , Células MCF-7 , Masculino , Metanol/química , Ratones , Dolor/inducido químicamente , Dolor/tratamiento farmacológico , Corteza de la Planta/química , Extractos Vegetales/química , Extractos Vegetales/toxicidad , Plantas Medicinales/química , Ratas Wistar , Pruebas de Toxicidad Aguda
8.
Photobiomodul Photomed Laser Surg ; 38(7): 398-408, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32486898

RESUMEN

Background: Temporomandibular disorder (TMD) refers to a group of disorders affecting the temporomandibular joint (TMJ) and its related muscles. The two commonly used treatment modalities for TMD are occlusal splint therapy and relaxation therapy. Neither comprises definitive treatment. Objective: The objective of this review was to report updated information on photobiomodulation and stem cells, as an alternative treatment for the degenerative TMJ disc as a part of TMJ disorders. Materials and methods: With only a few research studies reported till date, this review also proposes the mechanism of laser irradiation on inflammatory mediators to treat TMD. Results: Photobiomodulation of stem cells with and without scaffolds could be used indirectly or directly as modulation of degenerative changes of the TMJ disc. Conclusions: The need for a distinct shift of the research margin in this field of dentistry is evident, specifically regarding the application of photobiomodulation and stem cells for tissue engineering of the TMJ disc.


Asunto(s)
Terapia por Luz de Baja Intensidad , Trasplante de Células Madre , Trastornos de la Articulación Temporomandibular/terapia , Humanos
9.
Biomed Pharmacother ; 103: 1079-1085, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29710666

RESUMEN

The present study explores the effect of Syzygium calophyllifolium bark methanol (SCBM) extract on pain and inflammation as cancer associated symptoms. The anti-proliferative and cell death-inducing ability of the extract was analysed using MCF-7 breast cancer cells. ATP and LDH levels, along with the cell morphology were noted. The anti-proliferative ability of the extract was examined in relation to pain and inflammation. Analgesic activity was determined using a hot plate, acetic acid and formalin-induced pain models in mice. Acute anti-inflammatory activity was observed in carrageenan and egg albumin induced paw oedema in Wistar rats. Chronic inflammation was induced by placing a cotton pellet under the skin at the axial region of rats. Reduced ATP and increased LDH content indicated the cytotoxic effect of the extract. SCBM at 200 mg/kg dose depicted good activity in acetic acid (77.69%) and formalin (80.81%) induced pain models compared to the standard drug indomethacin. However, only a moderate activity was observed in the hot plate method (53.85%). The higher dose of SCBM was equally effective in anti-inflammatory models. The dose (200 mg/kg) significantly reduced the paw oedema in carrageenan (96.71%) and egg albumin models (54.24%) compared to the control. The chronic inflammation was also inhibited upto 70.46% by SCBM. These activities can be attributed to the phenolic compounds detected in HPLC. The outcome of the study states that the extract can reduce both acute and chronic inflammatory conditions and kill the cancer cells, proposing the dual role of SCBM in treating inflammatory pains in cancer. The result of these studies indicated that wild plants like Syzygium calophyllifolium could be taken forward for a detailed study to accomplish the demand for a better treatment against diseases.


Asunto(s)
Analgésicos/farmacología , Antiinflamatorios/farmacología , Antineoplásicos Fitogénicos/farmacología , Extractos Vegetales/farmacología , Syzygium/química , Analgésicos/aislamiento & purificación , Animales , Antiinflamatorios/aislamiento & purificación , Antineoplásicos Fitogénicos/aislamiento & purificación , Proliferación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Edema/tratamiento farmacológico , Edema/inmunología , Humanos , Inflamación , Células MCF-7 , Masculino , Ratones , Dolor/tratamiento farmacológico , Umbral del Dolor/efectos de los fármacos , Corteza de la Planta/química , Extractos Vegetales/aislamiento & purificación , Ratas Wistar
10.
Biomed Pharmacother ; 95: 167-174, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28843148

RESUMEN

Plants are considered as one of the best sources of diabetic therapy. Being a reliable and sustainable medicinal hub, this study directs the use of Syzygium mundagam in exploring the antidiabetic property. Streptozotocin-Nicotinamide (STZ-NA) induced diabetic rats were treated with Syzygium mundagam bark methanol extract (SMBM). Based on acute toxicity study, the doses of the extract were fixed as 100 and 200mg/kg. Glibenclamide was used as reference drug. The blood glucose level and body weight of the rats were monitored for 28days. After the treatment, rats were sacrificed and the blood biochemical, serum and histopathological parameters were analysed. The in vivo antioxidant levels in liver and kidney were also estimated. SMBM extract (200mg/kg) could significantly reduce the blood glucose level from 580.60mg/dL to 237.60mg/dL on day 28. An accelerated reduction in body weight was observed in diabetic control rats and inhibited by the extract during the study. The haematological parameters were normal compared to normal rats. The values of serum parameters like triglycerides, high-density lipoprotein (HDL), cholesterol and very low-density lipoprotein (VLDL) were close to the values of normal rats. After the treatment, Superoxide dismutase (SOD), Glutathione (GSH) and Glutathione reductase (GR) levels in liver and kidney were found accountable for their antioxidant properties during diabetic condition. The degree of protection set by SMBM extract was clear enough in the histopathology of liver, kidney and pancreas. The phenolic compounds studied in SMBM can be related to these activities. This study proves the ability of Syzygium mundagam to combat the diabetic condition and provides an insight on hidden properties of plants which can be utilized as novel drugs for existing disease complications.


Asunto(s)
Complicaciones de la Diabetes/tratamiento farmacológico , Diabetes Mellitus Experimental/tratamiento farmacológico , Metanol/administración & dosificación , Corteza de la Planta , Extractos Vegetales/administración & dosificación , Syzygium , Administración Oral , Animales , Glucemia/efectos de los fármacos , Glucemia/metabolismo , Complicaciones de la Diabetes/sangre , Complicaciones de la Diabetes/patología , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/patología , Femenino , Hipoglucemiantes/administración & dosificación , Hipoglucemiantes/aislamiento & purificación , Masculino , Ratones , Extractos Vegetales/aislamiento & purificación , Ratas , Ratas Wistar , Resultado del Tratamiento
11.
Biomed Pharmacother ; 94: 781-786, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28802230

RESUMEN

Diabetic wounds have been identified as one of the major complications associated with diabetes. This study features the use of Syzygium mundagam bark methanol (SMBM) extract in the treatment of wounds in Streptozotocin-Nicotinamide induced diabetic rats. The extract ointment base, at 1 and 2% respectively, was applied to the wounded areas on the rats and monitored for 21days. The wound closure, epithelialization period and histopathology of the wounds were evaluated during the study. Both the concentrations of the extract (1% and 2%) healed the wounds even under diabetic conditions induced in rats on day 21 (99.69% and 100% respectively). The 2% SMBM treated animals showed a higher rate of epithelialization of the wound (15±0.49days). The histopathology of the wounded skin on day 10 revealed that the rats treated with SMBM extract could initiate the healing and re-epithelialization. This was evident from the migration of neutrophils and proliferation of fibroblasts. On the 21st day, complete healing of the skin could be observed in the rats treated with 2% extract which was evident from the newly formed epidermis, collagen fibers and fibroblast. The results compared well with those treated with betadine (5%). The results of this study will support the use of this plant extract for diabetic healing over the use of commercially available synthetic drugs.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Extractos Vegetales/farmacología , Syzygium/química , Cicatrización de Heridas/efectos de los fármacos , Animales , Movimiento Celular , Diabetes Mellitus Experimental/complicaciones , Diabetes Mellitus Experimental/patología , Femenino , Fibroblastos/metabolismo , Metanol/química , Ratones , Neutrófilos/metabolismo , Extractos Vegetales/administración & dosificación , Povidona Yodada/farmacología , Ratas , Ratas Wistar , Piel/efectos de los fármacos , Piel/patología , Estreptozocina
12.
Biomed Pharmacother ; 83: 1278-1285, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27567587

RESUMEN

Passiflora subpeltata has many beneficial effects in the treatment of various diseases including inflammation, pain and fever. This study was aimed to analyze the phytochemical compounds present in acetone extract of P. subpeltata leaves and to evaluate their performance against paracetamol induced hepatotoxicity activity. HPLC-DAD method was used to identify and quantify the phytochemical compounds. Hepatoprotective activity of acetone extract in the treatment of rat liver functions was monitored by the measurement of blood parameters and serum biochemical parameters such as SGOT, SGPT, ALP and in vivo antioxidant parameters viz. SOD, CAT and LPO. Further, liver tissues were also subjected to histopathological analysis. The HPLC-DAD results showed the luteolin and quercetin 3-ß-d-glucoside as newly identified compounds in P. subpeltata species. Pre-treatment with acetone extract of P. subpeltata leaves at 200 and 400mg/kg doses significantly elevated the WBC, RBC and HB counts and retained the serum biochemical and enzymatic antioxidants levels to normal level. Based on this detailed study we conclude that acetone extract of P. subpeltata leaves offered better protection against hepatotoxicity induced by the acetaminophen.


Asunto(s)
Acetaminofén/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Luteolina/uso terapéutico , Passiflora , Extractos Vegetales/uso terapéutico , Quercetina/uso terapéutico , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Luteolina/aislamiento & purificación , Masculino , Ratones , Extractos Vegetales/aislamiento & purificación , Hojas de la Planta , Quercetina/aislamiento & purificación , Ratas , Ratas Wistar , Resultado del Tratamiento
13.
Biomed Pharmacother ; 82: 547-54, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27470395

RESUMEN

The study was initiated to determine the antidaibetic activity of Syzygium calophyllifolium in Streptozotocin-Nicotinamide (STZ-NA) induced diabetic rats. The rats were treated with 100 and 200mg/kg of the Syzygium calophyllifolium bark methanol extract (SCBM) and compared with the diabetic, normal and standard glibenclamide groups. The blood glucose level and body weight of the rats in different groups were monitored at regular intervals. The serum, blood biochemical and histopathological parameters of liver, kidney and pancreas were also analyzed. In vivo antioxidants like SOD, CAT, GST, GSH and GR levels were estimated in liver and kidney. SCBM (100mg/kg) extract could reduce the blood glucose level from the 15th day itself (213.67mg/dL) and the best reduction was observed till the end of the study with 259.25mg/dL (200mg/kg). Initial decrease in body weight was recovered after drug treatment and an increase in body weight was observed on the 4th week. The haematological parameters like total haemoglobin, packed cell volume percentage, total WBC and RBC content were found normal compared to that of normal untreated rats. Glibenclamide was also equally effective. The higher dose of SCBM extract could normalize the triglycerides, HDL, cholesterol and VLDL constituents in blood serum to the levels almost similar to that of normal rats. The results of the in vivo antioxidant levels showed that there are no significant difference in SOD, GSH and GR levels in all the groups compared to the normal control. SCBM and SMBM at 200mg/kg dose were much effective over the lower dose. The histology revealed that SCBM 200mg/kg could protect the cellular architecture of liver kidney and pancreas. The results from the study confirm ethnopharmacological significance of the plant and could be taken further for the development of an effective pharmaceutical drug against diabetes.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Hipoglucemiantes/uso terapéutico , Extractos Vegetales/uso terapéutico , Syzygium/química , Animales , Antioxidantes/metabolismo , Peso Corporal/efectos de los fármacos , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Tipo 2/sangre , Hipoglucemiantes/farmacología , Riñón/efectos de los fármacos , Riñón/patología , Hígado/efectos de los fármacos , Hígado/patología , Ratones , Niacinamida , Páncreas/efectos de los fármacos , Páncreas/patología , Corteza de la Planta/química , Extractos Vegetales/farmacología , Ratas , Ratas Wistar , Estreptozocina
14.
ScientificWorldJournal ; 2013: 890451, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24288509

RESUMEN

The leaf of C. dipsaceus was evaluated for its nutritional and antioxidant properties. From the present investigation, significant amount of almost all essential amino acids and important minerals were quantified. Low levels of trypsin inhibitory units, phenolics, and tannins content were found as antinutritional content. Further, hot water extract of C. dipsaceus showed good activity especially in ABTS(+), metal chelating, nitric oxide, and DPPH assays. Hence, the results conclude that C. dipsaceus could be a valuable nutraceutical supplement to the human diet.


Asunto(s)
Antioxidantes/análisis , Cucumis/química , Análisis de los Alimentos , Cucumis/anatomía & histología , Hojas de la Planta/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA